arrow
C

Christina Schjellerup Eickhardt-Dalbøge

University of Southern Denmark
H指数:8
被引数:223

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Interferon-α vs hydroxyurea in patients with myeloproliferative neoplasms (DALIAH): a multicentre, randomised, open-label, phase 3 trial in Denmark

干扰素-α与羟基脲在骨髓增殖性肿瘤患者中的比较(DALIAH):一项在丹麦进行的为期3期的多中心、随机、开放标签临床试验

2026-09-010
OAAI
The JAK2V617F and CALR mutations and risk of cancer, cardiovascular diseases, and all-cause mortality

JAK2V617F和CALR突变与癌症、心血管疾病及全因死亡率的风险

2025-11-060
OAAI
Statins Enhance the Efficacy of Pegylated Interferon-α2 in Philadelphia-Negative Chronic Myeloproliferative Neoplasms

他汀类药物增强聚乙二醇干扰素-α2在费城染色体阴性慢性骨髓增殖性肿瘤中的疗效

2025-09-220
OAAI
Statins Enhance the Efficacy of Pegylated Interferon-alpha2 in Patients with Ph-Negative Chronic Myeloproliferative Neoplasms. Results from a Danish Single-Institution Cohort Study

他汀类药物增强聚乙二醇干扰素-α2在Ph阴性慢性骨髓增殖性肿瘤患者中的疗效。丹麦单机构队列研究的结果。

BLOOD
IF23.1
2024-11-051
PRE
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study
2024-02-099
OAAI
Pronounced gut microbiota signatures in patients with JAK2V617F- positive essential thrombocythemia
2023-10-171
OAAI
The gut microbiota in patients with polycythemia vera is distinct from that of healthy controls and varies by treatment
2023-07-112
OAAI
Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis

病例报告: 对具有不确定潜能的CALR阳性克隆造血发展为纤维化前骨髓纤维化的患者的首次纵向研究

2023-05-082
OAAI